Thrombin Has Biphasic Effects on the Nitric Oxide-cGMP Pathway in Endothelial Cells and Contributes to Experimental Pulmonary Hypertension
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thrombin Has Biphasic Effects on the Nitric Oxide-cGMP Pathway in Endothelial Cells and Contributes to Experimental Pulmonary Hypertension
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 6, Pages e63504
Publisher
Public Library of Science (PLoS)
Online
2013-06-14
DOI
10.1371/journal.pone.0063504
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension
- (2012) Grazyna Kwapiszewska et al. CIRCULATION RESEARCH
- A role for coagulation factor Xa in experimental pulmonary arterial hypertension
- (2011) Martina Delbeck et al. CARDIOVASCULAR RESEARCH
- Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
- (2011) Johannes-Peter Stasch et al. CIRCULATION
- cGMP increases antioxidant function and attenuates oxidant cell death in mouse lung microvascular endothelial cells by a protein kinase G-dependent mechanism
- (2010) R. Scott Stephens et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Thrombin activation of proteinase-activated receptor 1 potentiates the myofilament Ca2+ sensitivity and induces vasoconstriction in porcine pulmonary arteries
- (2010) Jun Maki et al. BRITISH JOURNAL OF PHARMACOLOGY
- Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension
- (2010) Jing Huang et al. EXPERIMENTAL LUNG RESEARCH
- Role of apoptosis in pulmonary hypertension: From experimental models to clinical trials
- (2010) Paul Jurasz et al. PHARMACOLOGY & THERAPEUTICS
- Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
- (2010) Gautam Ramani Drug Design Development and Therapy
- Tissue Factor Pathway Inhibitor Overexpression Inhibits Hypoxia-Induced Pulmonary Hypertension
- (2009) Thomas A. White et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Is thrombin a key player in the 'coagulation-atherogenesis' maze?
- (2009) J. I. Borissoff et al. CARDIOVASCULAR RESEARCH
- Discovery of Riociguat (BAY 63-2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension
- (2009) Joachim Mittendorf et al. ChemMedChem
- First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
- (2009) F. Grimminger et al. EUROPEAN RESPIRATORY JOURNAL
- Tadalafil, a Long-Acting Inhibitor of PDE5, Improves Pulmonary Hemodynamics and Survival Rate of Monocrotaline-Induced Pulmonary Artery Hypertension in Rats
- (2009) Fusae Sawamura et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Thrombin physiology and pathophysiology
- (2009) Louis G. Licari et al. JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE
- Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 Activation
- (2008) Keren Borensztajn et al. AMERICAN JOURNAL OF PATHOLOGY
- Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling
- (2008) Martina Klein et al. CIRCULATION
- Phosphodiesterase inhibitors for the treatment of pulmonary hypertension
- (2008) M. R. Wilkins et al. EUROPEAN RESPIRATORY JOURNAL
- Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension
- (2008) R. T. Schermuly et al. EUROPEAN RESPIRATORY JOURNAL
- Coagulation signalling following tissue injury: Focus on the role of factor Xa
- (2008) M KRUPICZOJC et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Factor Xa: at the crossroads between coagulation and signaling in physiology and disease
- (2008) Keren Borensztajn et al. TRENDS IN MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started